We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01401309
First Posted: July 25, 2011
Last Update Posted: February 21, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Southwestern Regional Medical Center
January 24, 2011
July 25, 2011
February 21, 2014
January 2011
November 2011   (Final data collection date for primary outcome measure)
Detecting [ Time Frame: Jan 2011 - Nov 2011 ]
To exam if there is an improved sensitivity in detecting hepatic lesions using respiratory gating and if there is improvement in confidence defining lesions as benign or malignant
Not Provided
Complete list of historical versions of study NCT01401309 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer
Effects of Respiratory Gating on FDG/PET Detection of Hepatic Metastasis in Patients With Colon Cancer
This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Patients with colon cancer
Colon Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
81
March 2013
November 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with colon cancer
  • 18 years or older
  • Signed Informed Consent Form
  • Blood Glucose of 200 or less prior to scan

Exclusion Criteria:

  • Patients with known hepatic metastasis
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01401309
SRMC 10-07
Yes
Not Provided
Not Provided
Southwestern Regional Medical Center
Southwestern Regional Medical Center
Not Provided
Not Provided
Southwestern Regional Medical Center
February 2014